Biocon zooms on introducing ‘CIMIVIR-L’ for treatment of Hepatitis-C in India

24 Dec 2015 Evaluate

Biocon is currently trading at Rs. 508.00, up by 26.25 points or 5.45% from its previous closing of Rs. 481.75 on the BSE.

The scrip opened at Rs. 485.05 and has touched a high and low of Rs. 510.50 and Rs. 484.00 respectively. So far 130873 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 495.70 on 15-Apr-2015 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 510.50 and Rs. 477.90 respectively. The current market cap of the company is Rs. 10152.00 crore.

The promoters holding in the company stood at 61.02% while Institutions and Non-Institutions held 19.21% and 19.76% respectively.

Biocon, Asia’s premier biotechnology company, has introduced an advanced novel therapy CIMIVIR-L for the treatment of Hepatitis C in India. CIMIVIR-L is a fixed dose combination of Ledipasvir 90 mg and Sofosbuvir 400 mg, which is an equivalent of the innovator product commercialized by Gilead Sciences in the US. The Drugs Controller General of India (DCGI) recently approved the sale of Sofosbuvir- Ledipasvir combination, which is being manufactured in India under a license from Gilead.

CIMIVIR-L, a once-a-day oral therapy, will offer a convenient, effective and safe alternative to people infected with the Hepatitis-C virus (HCV). It is estimated that nearly one lakh people die annually in India from HCV infection and co-morbidities. CIMIVIR-L is indicated for Hepatitis-C Genotype 1 patients who account for 25% of the total estimated HCV patient population of 18 million in the country.

CIMIVIR-L will be made available to patients in India at a fraction of the global cost of the innovator brand. The cost of a 12-week course of this combination therapy in the US is $94,500.

 

Biocon Share Price

392.80 4.55 (1.17%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×